行情

JAGX

JAGX

Jaguar Health
NASDAQ

实时行情|Nasdaq Last Sale

1.460
-0.130
-8.18%
盘后: 1.530 +0.07 +4.79% 19:48 09/18 EDT
开盘
1.590
昨收
1.590
最高
1.594
最低
1.410
成交量
115.52万
成交额
--
52周最高
175.00
52周最低
1.000
市值
6,022.38万
市盈率(TTM)
-0.0001
分时
5日
1月
3月
1年
5年

分析师评级

2位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

JAGX 新闻

  • 中金宏观:预计美联储将在今年4季度再降息25bps
  • 新浪财经综合.4小时前
  • 美联储2个月内再次降息 美股短线跳水 中国跟不跟?
  • 新京报网.5小时前
  • 美联储第二次降息! 连磕"猛药"美国经济到底怎么了?
  • 新浪财经综合.5小时前
  • 美联储二度降息落地:内部分歧加大 年内或不再降息
  • 澎湃新闻.6小时前

更多

所属板块

生物技术和医学研究
-0.65%
制药与医学研究
-0.05%

热门股票

名称
价格
涨跌幅

JAGX 简况

Jaguar Health, Inc., formerly Jaguar Animal Health, Inc., is a natural-products pharmaceuticals company. The Company is focused on developing and commercializing novel, sustainably derived gastrointestinal products for both human prescription use and animals on a global basis. The Company, through its subsidiary Napo Pharmaceuticals, Inc., is focused on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas. Its Mytesi is an antidiarrheal indicated for the symptomatic relief of noninfectious diarrhea in adult patients with human immunodeficiency virus HIV/ acquired immune deficiency syndrome (AIDS) on antiretroviral therapy. Its other products include Canalevia, Equilevia, Neonorm Calf and Neonorm Foal.
展开

Webull提供Jaguar Health Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。